Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.
Abdelhalim
Ahmed
A
Barcos
Maurice
M
Block
Annemarie W
AW
Sait
Sheila N J
SN
Starostik
Petr
P
Wetzler
Meir
M
Wang
Eunice S
ES
D001921:Brain / Q000473:pathology; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D000069439:Dasatinib; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D020128:Inhibitory Concentration 50; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D013844:Thiazoles / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib